Elvitegravir
id:
elvitegravir-249-12978366
title:
Elvitegravir
text:
Elvitegravir (EVG) is an integrase inhibitor used to treat HIV infection. It was developed by the pharmaceutical company Gilead Sciences, which licensed EVG from Japan Tobacco in March 2008. The drug gained approval by the U.S. Food and Drug Administration on August 27, 2012, for use in adult patients starting HIV treatment for the first time as part of the fixed dose combination known as Stribild. On September 24, 2014, the FDA approved Elvitegravir as a single pill formulation under the trade
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Elvitegravir
date created:
date modified:
2023-11-07T11:30:05Z
main entity:
{"identifier":"Q2740966","url":"https://www.wikidata.org/entity/Q2740966"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/3/3e/Elvitegravir_structure.svg","width":622,"height":346}
fields total:
13
integrity:
15